The influence of information on drug resistance on protocol design
- 1 February 1991
- journal article
- review article
- Published by Elsevier in Annals of Oncology
- Vol. 2 (2) , 93-106
- https://doi.org/10.1093/oxfordjournals.annonc.a057892
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Primary Chemotherapy To Avoid Mastectomy in Tumors With Diameters of Three Centimeters or MoreJNCI Journal of the National Cancer Institute, 1990
- Primary Chemotherapy Can Avoid Mastectomy, but There Is More to It Than ThatJNCI Journal of the National Cancer Institute, 1990
- High dose chemo-radiotherapy for sensitive tumors: Is sequential better than concurrent drug delivery?European Journal of Cancer and Clinical Oncology, 1989
- Inhibition of Multidrug-resistant Human Tumor Growth in Athymic Mice by Anti-P-glycoprotein Monoclonal AntibodiesJapanese Journal of Cancer Research, 1989
- A Randomized Clinical Trial Evaluating Sequential Methotrexate and Fluorouracil in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor-Negative TumorsNew England Journal of Medicine, 1989
- Does P-glycoprotein Predict Response to Chemotherapy?JNCI Journal of the National Cancer Institute, 1989
- MECHANISMS OF MULTIDRUG RESISTANCE AND IMPLICATIONS FOR THERAPYJapanese Journal of Cancer Research, 1988
- Multiple-Drug Resistance in Human CancerNew England Journal of Medicine, 1987
- The basis of multidrug resistance in mammalian cells: Homology with bacterial transportCell, 1986
- The Evolution of Therapeutic Research in CancerNew England Journal of Medicine, 1978